Carmex Cold Sore Treatment Claims Exceed Monograph Limit In NAD Review
This article was originally published in The Rose Sheet
Executive Summary
Carma Labs’ Carmex Cold Sore Treatment claims did not mirror language in two OTC monographs for its active ingredients, the National Advertising Division says in a review of packaging and advertising claims challenged by GlaxoSmithKline's consumer business.